The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blass, S. L.
Right arrow Articles by Hunter, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blass, S. L.
Right arrow Articles by Hunter, C. A.
The Journal of Immunology, 2001, 166: 5726-5732.
Copyright © 2001 by The American Association of Immunologists

A Role for CD44 in the Production of IFN-{gamma} and Immunopathology During Infection with Toxoplasma gondii1

Sarah L. Blass*, Ellen Puré{dagger},{ddagger} and Christopher A. Hunter2,*

* Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104; {dagger} Wistar Institute, Philadelphia, PA 19104; and {ddagger} The Ludwig Institute for Cancer Research, New York, NY 10058

The interaction of activated CD44 with its ligand, low m.w. hyaluronan, is involved in inflammation, but no role has been identified for this interaction in the regulation of an immune response to infection. In these studies, infection of C57BL/6 mice with Toxoplasma gondii resulted in increased expression of CD44 on T cells, B cells, NK cells, and macrophages, and a small percentage of CD4+ T cells express an activated form of CD44. Administration of anti-CD44 to infected mice prevented the development of a CD4+ T cell-dependent, infection-induced inflammatory response in the small intestine characterized by the overproduction of IFN-{gamma}. The protective effect of anti-CD44 treatment was associated with reduced production of IFN-{gamma}, but not IL-12, in vivo and in vitro. Furthermore, the addition of low m.w. hyaluronan to cultures of splenocytes or purified CD4+ T cells from infected mice resulted in the production of high levels of IFN-{gamma}, which was dependent on IL-12 and TCR stimulation. Together, these results identify a novel role for CD44 in the regulation of IFN-{gamma} production by CD4+ T cells during infection and demonstrate a role for CD44 in the regulation of infection-induced immune pathology.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
M. K. Middleton, A. M. Zukas, T. Rubinstein, M. Kinder, E. H. Wilson, P. Zhu, I. A. Blair, C. A. Hunter, and E. Pure
12/15-Lipoxygenase-Dependent Myeloid Production of Interleukin-12 Is Essential for Resistance to Chronic Toxoplasmosis
Infect. Immun., December 1, 2009; 77(12): 5690 - 5700.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. M. A. Rouschop, M. Sylva, G. J. D. Teske, I. Hoedemaeker, S. T. Pals, J. J. Weening, T. van der Poll, and S. Florquin
Urothelial CD44 Facilitates Escherichia coli Infection of the Murine Urinary Tract
J. Immunol., November 15, 2006; 177(10): 7225 - 7232.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
C.-P. Yang, S. M. Sparshott, D. Duffy, P. Garside, and E. B. Bell
The phenotype and survival of antigen-stimulated transgenic CD4 T cells in vivo: the influence of persisting antigen
Int. Immunol., April 1, 2006; 18(4): 515 - 523.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J.-S. Lin and B. A. Wu-Hsieh
Functional T cells in primary immune response to histoplasmosis
Int. Immunol., November 1, 2004; 16(11): 1663 - 1673.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. I. Buzas, A. Hanyecz, Y. Murad, F. Hudecz, E. Rajnavolgyi, K. Mikecz, and T. T. Glant
Differential Recognition of Altered Peptide Ligands Distinguishes Two Functionally Discordant (Arthritogenic and Nonarthritogenic) Autoreactive T Cell Hybridoma Clones
J. Immunol., September 15, 2003; 171(6): 3025 - 3033.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
E. Eriksson, L. Dons, A. G. Rothfuchs, P. Heldin, H. Wigzell, and M. E. Rottenberg
CD44-Regulated Intracellular Proliferation of Listeria monocytogenes
Infect. Immun., July 1, 2003; 71(7): 4102 - 4111.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
J. Cichy and E. Pure
The liberation of CD44
J. Cell Biol., June 9, 2003; 161(5): 839 - 843.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Cichy, R. Bals, J. Potempa, A. Mani, and E. Pure
Proteinase-mediated Release of Epithelial Cell-associated CD44. EXTRACELLULAR CD44 COMPLEXES WITH COMPONENTS OF CELLULAR MATRICES
J. Biol. Chem., November 8, 2002; 277(46): 44440 - 44447.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
R. A. O'Connor and E. Devaney
Nitric Oxide Limits the Expansion of Antigen-Specific T Cells in Mice Infected with the Microfilariae of Brugia pahangi
Infect. Immun., November 1, 2002; 70(11): 5997 - 6004.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. N. Villegas, L. A. Lieberman, N. Mason, S. L. Blass, V. P. Zediak, R. Peach, T. Horan, S. Yoshinaga, and C. A. Hunter
A Role for Inducible Costimulator Protein in the CD28- Independent Mechanism of Resistance to Toxoplasma gondii
J. Immunol., July 15, 2002; 169(2): 937 - 943.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. J. D. Mennechet, L. H. Kasper, N. Rachinel, W. Li, A. Vandewalle, and D. Buzoni-Gatel
Lamina Propria CD4+ T Lymphocytes Synergize with Murine Intestinal Epithelial Cells to Enhance Proinflammatory Response Against an Intracellular Pathogen
J. Immunol., March 15, 2002; 168(6): 2988 - 2996.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.